HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

474.600

+24.6005.47%

Volume:200.55K

Turnover:94.15M

Market Cap:42.18B

PE:-565.66

High:500.000

Open:450.000

Low:421.000

Close:450.000

52wk High:765.500

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:1.35

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:46.56

PE(LYR):-565.66

PS:196.86

Loading ...

Overview Company News Filings

DIAGENS-B (02526) Debuts with 121.21% Surge in Early Trading, Focused on Medical Imaging AI Platform

Shares of Shandong Extreme Vision Set to Open at HK$59.95 Each in Hong Kong Debut VS Offer Price HK$40 Apiece

THOMSON REUTERS

Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut

MT Newswires Live

Hangzhou Diagens Biotechnology - Final Offer Price of HK$99.0 per H Share

THOMSON REUTERS

DIAGENS-B Soars Over 110% in Pre-Market Trading, Signaling Strong Debut for Medical AI Giant

Unlisted Trading Shows DIAGENS-B (02526) Surging Over 87% at Opening, Generating HK$4,310 Per Lot

Diagens Soared 82% In Hong Kong’s Grey Market Trading

MT Newswires Live

Hangzhou Diagens Biotechnology Defines Comprehensive Mandate for Board Nomination Committee Ahead of HKEX Listing

Bulletin Express

Diagens Updates Articles of Association in Preparation for Hong Kong H-Share Listing

Bulletin Express

Diagens Establishes Comprehensive Audit Committee Framework to Strengthen Financial Oversight

Bulletin Express

IPO Margin Financing Statistics as of March 24

DIAGENS-B Poised to Lead Hong Kong IPO Pipeline Amid "Dream Valuation" Frenzy

Margin Financing Statistics for New Listings as of March 23

Medical Imaging AI Pioneer Deshi's IPO Attracts Strong Long-Term Fund Interest

Weekly IPO Review: Three New Listings Available for Subscription, Leading Mobile PCB Maker Enters Market

DIAGENS-B: Medical Imaging AI Specialist with 8.4 Billion Float Shares - New Stock Analysis for March 2026 (02526.HK)

IPO Margin Financing Statistics for March 20

Landmark Listing: DIAGENS-B (02526) Debuts on HKEX as AI Healthcare's Pioneering Stock

Hangzhou Diagens Biotechnology (02526) Launches Global Offering, Targeting Up to HK$112.50 per Share

Bulletin Express

BRIEF-Hangzhou Diagens Biotechnology Announces Global Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/02526/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":474.6,"timestamp":1789114135003,"preClose":450,"halted":0,"volume":200545,"delay":0,"changeRate":0.05466666666666672,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Closed","change":24.6,"latestTime":"09-11 16:08:55","open":450,"high":500,"low":421,"amount":94148027,"amplitude":0.175556,"askPrice":474.6,"askSize":25900,"bidPrice":472,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":450,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.34644,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":1.34644,"shares":88879200,"dividePrice":0,"high":500,"amplitude":0.175556,"preClose":450,"low":421,"week52Low":178,"pbRate":"46.56","psRate":"196.86","week52High":765.5,"institutionHeld":0,"latestPrice":474.6,"committee":-0.996146,"eps":-0.839024,"divideRate":0,"volume":200545,"delay":0,"ttmEps":-1.576,"open":450,"prevYearClose":99,"prevWeekClose":495.6,"prevMonthClose":529,"prevQuarterClose":309.8,"fiveDayClose":495.6,"twentyDayClose":370,"sixtyDayClose":318.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-09-10","current":-301.142132,"percent":0.881818,"low":-545.299386,"twenty":-394.481072,"median":-348.881041,"eighty":-310.958904,"high":-208.205701,"avg":-352.647706,"sd":64.804778,"marketCap":39995640000},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200},{"date":"2026-08-28","current":-306.753265,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"marketCap":43533032160},{"date":"2026-09-04","current":-310.261155,"twenty":-396.494596,"median":-351.396357,"eighty":-315.297789,"marketCap":44048531520},{"date":"2026-09-10","current":-281.310066,"twenty":-394.481072,"median":-348.881041,"eighty":-310.958904,"marketCap":39995640000}],"updateTime":1789124630787},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146284525","title":"DIAGENS-B (02526) Debuts with 121.21% Surge in Early Trading, Focused on Medical Imaging AI Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1146284525","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146284525?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:31","pubTimestamp":1774834273,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) made its trading debut today. According to the company's announcement, the IPO price was set at HKD 99 per share, with a total of 7,999,200 shares issued. Each board lot consists of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1189","02251"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623364305","title":"Shares of Shandong Extreme Vision  Set to Open at HK$59.95 Each in Hong Kong Debut VS Offer Price HK$40 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2623364305","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623364305?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:21","pubTimestamp":1774833674,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL4N40I04H:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526","01021","06636","02726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623336322","title":"Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2623336322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623336322?lang=en_us&edition=fundamental","pubTime":"2026-03-30 06:15","pubTimestamp":1774822524,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology  raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.The Chinese biotechnology company offered 8.0 million H-shares in the global offering.The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622782982","title":"Hangzhou Diagens Biotechnology - Final Offer Price of HK$99.0 per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622782982","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622782982?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:12","pubTimestamp":1774613567,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0CR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169716686","title":"DIAGENS-B Soars Over 110% in Pre-Market Trading, Signaling Strong Debut for Medical AI Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=1169716686","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169716686?lang=en_us&edition=fundamental","pubTime":"2026-03-27 17:45","pubTimestamp":1774604715,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526), set to list on the Hong Kong Stock Exchange next Monday (March 30), delivered a remarkable performance in pre-market trading on March 27. The stock surged significantly, reaching a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","150261"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117296289","title":"Unlisted Trading Shows DIAGENS-B (02526) Surging Over 87% at Opening, Generating HK$4,310 Per Lot","url":"https://stock-news.laohu8.com/highlight/detail?id=1117296289","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117296289?lang=en_us&edition=fundamental","pubTime":"2026-03-27 16:37","pubTimestamp":1774600662,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) is scheduled to list on the Hong Kong exchange on March 30 (next Monday). As of the latest update, unlisted trading indicated a price of HK$185.2, representing an increase of 87.07%...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620220333","title":"Diagens Soared 82% In Hong Kong’s Grey Market Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2620220333","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620220333?lang=en_us&edition=fundamental","pubTime":"2026-03-27 16:18","pubTimestamp":1774599508,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology (HKG:2526) launched its Hong Kong initial public offering on Friday, seeking to raise up to HK$899.9 million from the deal.The China-based medical device maker is offeri","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195780676","title":"Hangzhou Diagens Biotechnology Defines Comprehensive Mandate for Board Nomination Committee Ahead of HKEX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1195780676","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195780676?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:26","pubTimestamp":1774563982,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. has released a detailed Terms of Reference outlining the structure, authority and operating rules of its newly established Nomination Committee, a key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153964762","title":"Diagens Updates Articles of Association in Preparation for Hong Kong H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1153964762","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153964762?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:26","pubTimestamp":1774563966,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B, stock code 02526) released a comprehensive draft of its Articles of Association, detailing governance, capital structure and shareholder rights as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186567077","title":"Diagens Establishes Comprehensive Audit Committee Framework to Strengthen Financial Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=1186567077","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186567077?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:24","pubTimestamp":1774563882,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. released detailed Terms of Reference for its Board-level Audit Committee, formalising responsibilities, composition requirements and working procedures that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148355022","title":"IPO Margin Financing Statistics as of March 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1148355022","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148355022?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:20","pubTimestamp":1774358428,"startTime":"0","endTime":"0","summary":"Several companies are currently undergoing their initial public offerings, including EXTREME VISION (06636), EPIWORLD (02726), TONGSHIFU (00664), HUAYAN ROBOTICS (01021), TONGRENTANGCARE (02667),...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06636","02667","02726","03625","01021","00664","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135199352","title":"DIAGENS-B Poised to Lead Hong Kong IPO Pipeline Amid \"Dream Valuation\" Frenzy","url":"https://stock-news.laohu8.com/highlight/detail?id=1135199352","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135199352?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:13","pubTimestamp":1774343604,"startTime":"0","endTime":"0","summary":"The AI foundation model sector has experienced a strong, independent market trend since the start of 2026, with \"dream valuation\" becoming a core metric for evaluating related companies. Among the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","02526","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185491299","title":"Margin Financing Statistics for New Listings as of March 23","url":"https://stock-news.laohu8.com/highlight/detail?id=1185491299","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185491299?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:31","pubTimestamp":1774269080,"startTime":"0","endTime":"0","summary":"Several companies are currently in the process of public offerings, including Extreme Vision (06636), EPIWORLD (02726), TONGSHIFU (00664), HUAYAN ROBOTICS (01021), TONGRENTANGCARE (02667), DIAGENS-B...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02667","02526","02726","03625","01021","06636","00664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175589388","title":"Medical Imaging AI Pioneer Deshi's IPO Attracts Strong Long-Term Fund Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=1175589388","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175589388?lang=en_us&edition=fundamental","pubTime":"2026-03-23 17:50","pubTimestamp":1774259450,"startTime":"0","endTime":"0","summary":"As artificial intelligence technology continues to advance, the integration of AI and healthcare is gradually moving from the laboratory to clinical applications. Medical AI, a typical high-barrier...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169747408","title":"Weekly IPO Review: Three New Listings Available for Subscription, Leading Mobile PCB Maker Enters Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1169747408","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169747408?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:12","pubTimestamp":1774224726,"startTime":"0","endTime":"0","summary":"This week's new share subscriptions feature industry leaders in mobile HDI mainboards and mobile battery boards. According to Wind data and public information, three new stocks are scheduled for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06636","301696","02667","603459","02726","01021","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198056909","title":"DIAGENS-B: Medical Imaging AI Specialist with 8.4 Billion Float Shares - New Stock Analysis for March 2026 (02526.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=1198056909","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198056909?lang=en_us&edition=fundamental","pubTime":"2026-03-22 22:31","pubTimestamp":1774189911,"startTime":"0","endTime":"0","summary":"This analysis is conducted from an institutional perspective, focusing on the company's business operations and market positioning. Readers are encouraged to follow for more institutional-grade...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","159883","BK1574","BK1100","BK1583","09997","BK1222","02526","02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129048439","title":"IPO Margin Financing Statistics for March 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1129048439","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129048439?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:50","pubTimestamp":1774003819,"startTime":"0","endTime":"0","summary":"Several companies, including DIAGENS-B (02526), TONGRENTANGCARE (02667), EXTREME VISION (06636), HUAYAN ROBOTICS (01021), and EPIWORLD (02726), are currently undergoing their initial public offering...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","06636","02726","01021","02667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134010766","title":"Landmark Listing: DIAGENS-B (02526) Debuts on HKEX as AI Healthcare's Pioneering Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1134010766","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134010766?lang=en_us&edition=fundamental","pubTime":"2026-03-20 15:15","pubTimestamp":1773990944,"startTime":"0","endTime":"0","summary":"The persistent challenges of \"difficult access to medical care and diagnosis\" represent a fundamental bottleneck hindering the improvement of public health standards globally. The lengthy training...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","HEXmain","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144797633","title":"Hangzhou Diagens Biotechnology (02526) Launches Global Offering, Targeting Up to HK$112.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1144797633","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144797633?lang=en_us&edition=fundamental","pubTime":"2026-03-20 06:33","pubTimestamp":1773959628,"startTime":"0","endTime":"0","summary":"Introduction   Hangzhou Diagens Biotechnology Co., Ltd. (Stock Code: 02526) is offering an aggregate of 7,999,200 H Shares through a Hong Kong Public Offering (799,950 H Shares) and an International...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620055402","title":"BRIEF-Hangzhou Diagens Biotechnology Announces Global Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2620055402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620055402?lang=en_us&edition=fundamental","pubTime":"2026-03-20 06:07","pubTimestamp":1773958045,"startTime":"0","endTime":"0","summary":"BRIEF-Hangzhou Diagens Biotechnology Announces Global OfferingMarch 20  - Hangzhou Diagens Biotechnology: MAXIMUM OFFER PRICE UNDER GLOBAL OFFERING HK$112.5 PER H SHARENUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 8 MILLION H SHARESUNDER GLOBAL OFFERING NUMBER OF HONG KONG OFFER SHARES 799,950 H SHARES ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN40719P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":100,"code":"91000000","status":"200"}]}}